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epatocyte growth factor (HGF)/Met signaling con-
trols cell migration, growth and differentiation in
several embryonic organs and is implicated in hu-
man cancer. The physiologic mechanisms that attenuate
Met signaling are not well understood. Here we report a
mechanism by which mitogen-inducible gene 6 (Mig6;
also called Gene 33 and receptor-associated late trans-
ducer) negatively regulates HGF/Met-induced cell migra-
tion. The effect is observed by Mig6 overexpression and
is reversed by Mig6 small interfering RNA knock-down
experiments; this indicates that endogenous Mig6 is part
H
 
of a mechanism that inhibits Met signaling. Mig6 functions
in cells of hepatic origin and in neurons, which suggests a
role for Mig6 in different cell lineages. Mechanistically,
Mig6 requires an intact Cdc42/Rac interactive binding
site to exert its inhibitory action, which suggests that
Mig6 acts, at least in part, distally from Met, possibly by
inhibiting Rho-like GTPases. Because Mig6 also is in-
duced by HGF stimulation, our results suggest that Mig6
is part of a negative feedback loop that attenuates Met
functions in different contexts and cell types.
 
Introduction
 
The signals that regulate the development of organs need to act
for a limited duration in the right place and time. To avoid sig-
naling errors that lead to aberrant cellular behavior and disease,
cellular mechanisms have evolved to ensure that appropriate
parameters of a signal are received and maintained for the cor-
rect time. Hepatocyte growth factor (HGF)/scatter factor acts
through the Met receptor tyrosine kinase to mediate a complex
process that is called invasive growth (Trusolino and Co-
moglio, 2002). This process combines cell proliferation with
cell–cell dissociation and movement, ECM degradation, and
survival. Met-mediated invasive growth plays key roles in
placenta, liver, and muscle development, as well as in certain
aspects of nervous system development (for review see Maina
and Klein, 1999; Birchmeier et al., 2003; see also Helmbacher
et al., 2003; Prunotto et al., 2004).
The signaling events that are activated by Met have been
well characterized and involve the concomitant activation of the
Ras/MAPK and phosphatidyl-inositol 3 (PI3) kinase pathways,
in addition to the recruitment and phosphorylation of the multi-
adaptor, GAB1 (Rosario and Birchmeier, 2003). It seems as if
many of the downstream pathways are functionally redundant
and extensively cross-wired. However, superimposed above a ge-
neric threshold signaling level, specific effectors seem to be re-
quired to achieve specific biologic functions (Maina et al., 2001).
Cell migration requires extensive remodeling of the cell
cytoskeleton, which is mediated by members of the Rho family
of small GTPases (for review see Labouesse, 2004). In their
active GTP-bound state, they interact with several effector
proteins. Many of these effectors share a common Cdc42-Rac
interactive binding (CRIB) domain. CRIB domain–containing
effectors are structurally and functionally diverse and include
protein kinases, actin binding proteins, and adaptor proteins,
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such as mitogen-inducible gene 6 (Mig6; see below next para-
graph) (for review see Pirone et al., 2001).
Signaling by receptor tyrosine kinases requires a counter-
balance by negative signaling events to ensure that appropriate
thresholds of receptor signals are achieved and maintained
for the right length of time. Irreversible inhibition is mediated
most commonly by activation-dependent protein degradation
through the ubiquitin–proteasome pathway. Reversible inhibi-
tion can be achieved by protein tyrosine phosphatases, by dual-
specificity MAPK phosphatases, and by phosphatase and ten-
sin homologue proteins, which down-regulate the PI3 kinase
pathway (Dikic and Giordano, 2003).
In a screen for HGF-induced changes in the transcrip-
tome of cultured cells, we identified the Mig6 adaptor protein
in a set of highly induced transcripts. Mig6 (also known as
Gene 33 and receptor-associated late transducer) is considered
an immediate early response gene that can be induced by a va-
riety of external stimuli, including growth factors, cytokines,
and stress factors (Wick et al., 1995; Makkinje et al., 2000; and
references within). Overexpression and knock-down studies
suggested that Mig6 was a selective inhibitor of EGF receptor
family (also known as ErbB receptors)–mediated mitogenesis
and transformation (Fiorentino et al., 2000; Hackel et al., 2001;
Fiorini et al., 2002; Anastasi et al., 2005; Xu et al., 2005). Its
mechanism of action, receptor specificity, and influence on
other cellular activities are poorly understood or unknown.
Here we show that Mig6 is a negative regulator of HGF/
Met-induced cell migration. The effect was observed by Mig6
overexpression and was reversed by Mig6 small interfering
RNA (siRNA) knock-down experiments, which indicates that
endogenous Mig6 is part of a mechanism that inhibits Met sig-
naling. The effect is observed in cells of hepatic origin as well
as in primary neurons; this suggests that Mig6 functions across
different cell lineages. Met lacks the sequence identified in
EGF receptor as the Mig6 binding region (Hackel et al., 2001)
and fails to bind Mig6 directly. Instead, Mig6 requires an intact
CRIB domain to exert its inhibitory action, and suggests that
Mig6 acts, at least in part, distal from the receptor, possibly by
interacting with Rho family GTPases. Because Mig6 also is in-
duced by HGF stimulation, our results suggest that Mig6 is part
of a negative feedback loop that attenuates Met signaling in a
variety of cellular functions.
Figure 1. Induction of Mig6 by HGF/Met
signaling in cultured cells and coexpression of
Mig6 with Met in vivo. (A–C) Northern blot
analysis showing mig6 mRNA up-regulation
upon HGF, FGF, or PDGF stimulation for 4 h
(A and B) or the indicated times (C) in MLP29
and C2C12 cells. 18S or glyceraldehyde
3–phosphate dehydrogenase (G3PDH) mRNA
levels were used as internal control. Western
blot (W.B.) analysis showing Mig6 protein in-
duction upon HGF and EGF stimulation in
MLP29 cells (D) and primary hepatocytes (E).
Cells were grown in 10% FBS, then stimulated
with empty media, 40 ng/ml HGF, or 10
ng/ml EGF for the indicated times, lysed, and
analyzed by SDS-PAGE and immunoblotting
using a specific anti-Mig6 antiserum. Immuno-
blots for  -tubulin and Met were used as
internal controls. Immunocytochemistry analy-
sis showing Mig6 protein induction upon HGF
stimulation in MLP29 cells. Cells stimulated as
above with empty media (F) or with HGF (G),
fixed, and stained using a specific anti-Mig6
antiserum. NT, not treated. Bar, 50  m. (H–N)
In situ hybridization analyses for mig6 and
met mRNA transcripts in selected organs of
E13.5 wild-type (
 / ) and Met signaling–defi-
cient (met
d/d) embryos. Co-expression of mig6
and met is observed in alveoli of the lungs
(Lu), liver (Li), intercostal muscle (i.m.), and
body wall muscle (b.w.) (I, J, M, and N).
Mig6 transcript levels are reduced in met
d/d
embryo lungs and liver (K). Mig6 sense probe
was used as negative control on adjacent sec-
tions (H, L). Ri, ribs. Bar, 300  m. 
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Results
 
Mig6 induction by HGF/Met signaling
 
Part of our efforts to understand the molecular events that con-
trol HGF/Met signaling has been to examine the expression of
genes that are regulated by Met signaling. RNA from HGF-
stimulated and unstimulated MLP29 cells, a liver-derived cell
line that expresses physiologic levels of Met (Medico et al.,
1996), was subjected to microarray analysis (Tanaka et al.,
2000). Genes that showed 
 
 
 
1.8-fold changes and whose sum
of median value was 
 
 
 
5,000 were included in the final list. Ex-
pression levels of 
 
 
 
100 genes were up-regulated, whereas 
 
 
 
30
genes were down-regulated by HGF stimulation in MLP29
cells (Tables SI and SII; available at http://www.jcb.org/cgi/
content/full/jcb.200502013/DC1). Analysis, by Northern blot-
ting, of selected candidates on two independent cell lineages
(MLP29 hepatic cells and C2C12 myoblast cells) confirmed
Met-mediated regulation of most hits from the microarray
analysis (Fig. S1 A).
Mig6 was chosen for further analysis because its expres-
sion was induced more strongly by HGF—4.5- to 80-fold by 4 h
of HGF stimulation—than by fibroblast growth factor 2 (FGF2)
or PDGF (Fig. 1, A and B). Other transcripts did not show this
preference for HGF (Fig. S1 B). The reduced response to FGF2
and PDGF was not due to lack of specific receptors or down-
stream transducers, because both growth factors induced robust
phosphorylation of ERK/MAPKs in MLP29 cells (Fig. S2; avail-
able at http://www.jcb.org/cgi/content/full/jcb.200502013/DC1).
Time courses of HGF stimulation revealed that Mig6 mRNA and
protein were induced half maximally after 1 h and maintained for
several hours (Fig. 1, C and D). The induction of Mig6 protein by
EGF was more transient than that induced by HGF (Fig. 1 D). In-
duction of Mig6 protein by HGF in primary hepatocytes fol-
lowed delayed kinetics (Fig. 1 E). We also confirmed the induc-
tion of endogenous Mig6 protein by immunostaining of MLP29
cells (Fig. 1, F and G). We next investigated the expression of
Mig6 and Met in embryonic tissues. By in situ hybridization
analysis, we found that both transcripts coexpressed in alveoli of
Figure 2. Mig6 overexpression inhibits HGF-mediated cell
migration. (A–C) MLP29 cells were transfected with a mixture of
YFP and Mig6
FL-V5 expression plasmids in a ratio of 1:5. 24 h
later, cells were starved in 0.1% FBS for an additional 24 h, har-
vested, and seeded onto coverslips for immunocytochemical
analysis. Cells were fixed and Mig6 overexpression was de-
tected using a Mig6-specific antibody (B). YFP-expressing cells
(A) are strongly positive for Mig6 (C). Bar, 50  m. (D–I) MLP29
cells were transfected with Mig6
FL-V5 or LacZ
V5 expression plas-
mids and stained with anti-Mig6 and anti-V5 antibodies as
above. LacZ
V5 transfected cells were weakly positive for (endoge-
nous) Mig6 and strongly positive for the V5 epitope (D–F).
Mig6
FL-V5 transfected cells showed strong costaining for Mig6
and V5 (G–I) indicating efficient overexpression of Mig6. (J)
Western blot (W.B.) using V5 antibodies to detect Mig6
FL-V5 or
LacZ
V5 expression. (K–N) Photographs of Hoechst dye–labeled
cells after migration through the Boyden chamber membrane.
Cells were transfected with the indicated expression plasmids as
described above, and a portion was seeded onto the upper face
of the membrane. Cells were exposed to 10% FBS (K and L) or
40 ng/ml HGF (M and N). Reduced migration due to Mig6 over-
expression was observed in the YFP-positive (see quantification
below) and in the total Hoechst dye–positive cell population
(compare M with N). Bar, 100  m. Quantification of migration
of YFP-expressing cells indicated as fold of induction over unstim-
ulated cells, in the absence (O) or presence (P) of the DNA poly-
merase inhibitor, aphidicolin. Mig6 overexpression reduced
HGF-stimulated cell migration by approximately threefold in
the absence (O; P   0.001, t test) or presence of aphidicolin
(P; P   0.001, t test). In contrast, cell migration stimulated
(Stim.) with 10% FBS in the absence or presence of aphidicolin
was unaffected by Mig6 overexpression (P   0.45 and P  
0.121, respectively; t test). 
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embryonic (E13.5) lung, in liver parenchyma, and in intercostal
and body wall muscles of wild-type embryos (Fig. 1, I, J, M, and
N). Consistent with Met regulating mig6 transcript levels under
physiologic conditions, we found reduced levels of mig6 mRNA
in embryos that expressed a signaling-deficient Met receptor
(
 
met
 
d/d
 
) (Maina et al., 1996, 2001) (Fig. 1 K). Expression of Mig6
protein was confirmed in structures positive for 
 
mig6
 
 mRNA,
including intercostal and body wall muscles (Fig. S2).
 
Overexpression of Mig6 inhibits HGF-
induced migration of MLP29 cells
 
The only cellular context in which Mig6 has been implicated is
cell division. However, because HGF/Met signaling is critical
for cell migration, we tested the effects of Mig6 overexpression
on HGF/Met-mediated migration in the Boyden chamber migra-
tion assay. This assay tests the capacity of cells to migrate
through a porous membrane that separates upper and lower
compartments. MLP29 cells were transfected with a plasmid
that encodes YFP, or cotransfected with plasmids that encode
full-length Mig6 (Mig6
 
FL
 
) and YFP (Fig. 2, A–C). We con-
firmed the expression of exogenous Mig6 by immunostaining of
cells and immunoblotting of lysates from cells expressing V5
epitope–tagged versions of Mig6 (Mig6
 
FL-V5
 
) in comparison
with V5 epitope–tagged 
 
 
 
-galactosidase (LacZ
 
V5
 
) (Fig. 2, D–J).
For each experimental condition, equal numbers of cells were
seeded onto coverslips for immunocytochemical analysis, or
onto the upper compartment of the Boyden chamber and were
exposed to varying concentrations of HGF or 10% FBS in the
lower compartment. Cell migration through the membrane into
the lower compartment was stimulated by HGF in a dose-depen-
dent manner (unpublished data). At 40 ng/ml HGF, migration of
transfected, YFP-positive cells was enhanced 30- to 40-fold
over unstimulated cells (Fig. 2, O and P). Representative images
of Hoechst dye–labeled cells, which migrated into the lower
compartment of the Boyden chamber, are shown in Fig. 2 (K–N).
The presence of Mig6
 
FL
 
 reduced HGF-stimulated cell migration
by approximately threefold (Fig. 2 O, P 
 
 
 
 0.001, 
 
t
 
 test). In con-
trast, cell migration that was stimulated with 10% FBS was un-
affected by Mig6 overexpression (P 
 
 
 
 0.121, 
 
t
 
 test).
Because Mig6 overexpression also reduced cell prolifera-
tion that was induced by HGF (unpublished data), we next
asked whether the effect on cell migration could be secondary
to reduced cell proliferation. Transfected cells were exposed to
1.6 
 
 
 
g/ml of the DNA polymerase inhibitor, aphidicolin, 24 h
before plating onto the membrane; the assay was conducted in
the presence of 1.6 
 
 
 
g/ml aphidicolin. Typically, aphidicolin
treatment reduced the incorporation of BrdU into MLP29 cells
10-fold (unpublished data). Under these conditions, HGF-
stimulated cell migration still was reduced significantly by
Mig6 overexpression which indicated that Mig6 had a direct
influence on Met-mediated cell migration, independently of its
effect on cell proliferation (Fig. 2 P; P 
 
 
 
 0.01, 
 
t
 
 test).
 
Mig6 is a physiologic suppressor of Met-
mediated cell migration
 
We next investigated, using RNA interference, whether endoge-
nous Mig6 suppressed HGF/Met-mediated cell migration by
Figure 3. Endogenous Mig6 inhibits HGF-induced cell migration in MLP29
cells. MLP29 cells were transfected with GFP-specific siRNAs as a negative
control (A) or with mig6-specific siRNAs (B) for 4 d, then fixed, and Mig6
protein levels were detected by immunofluorescence using a Mig6-specific
antibody (green label). (B) Cells were visualized using Hoechst dye. Note the
efficient knock-down of Mig6 protein levels upon transfection of mig6 si-
RNAs. Bar, 50  m. (C) Western blot (W.B.) analysis of MLP29 cells trans-
fected with GFP siRNAs ( ) or mig6-specific siRNAs ( ) for 4 d. After trans-
fection, the cells were stimulated with 40 ng/ml HGF for the indicated times
and the cell lysates were analyzed using SDS-PAGE and immunoblotting us-
ing  -Mig6– or  -tubulin–specific ( -Tub) antibodies. The specific reduction
of Mig6 levels is seen most clearly at the 4-h time point. (D–G) Representative
fields of GFP siRNA– and mig6 siRNA–transfected MLP29 cells (labeled with
Hoechst dye) that migrated into the lower compartment of the Boyden cham-
ber in the presence or the absence of HGF. MLP29 cells were treated as de-
scribed above, then transfected a second time with siRNA oligonucleotides,
incubated for 24h, harvested, plated into the upper compartment of the
Boyden chamber, and allowed to attach onto the membrane. Different con-
centrations of HGF were added to the media of the lower compartment of
the chamber and the cells were allowed to migrate for 16 h. Note the in-
crease of cell migration of mig6 knock-down cells after HGF stimulation
(compare panels F and G). Bar, 100  m. (H) Quantification of migration ex-
pressed as fold of induction over unstimulated cells. Increasing concentra-
tions of HGF were added to the lower chamber after transfection of control
GFP siRNAs (black bars) or mig6 siRNAs (gray bars). 5 ng/ml HGF, P  
0.02; 10 ng/ml HGF, P   0.0002; 40 ng/ml HGF, P   0.01, t test. 
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knocking down Mig6 protein levels (Elbashir et al., 2001).
MLP29 cells were transfected with siRNAs specific for GFP or
mig6, and the levels of Mig6 protein were analyzed by immuno-
staining and immunoblotting. Mig6 siRNA, but not control GFP
siRNA, specifically knocked down endogenous Mig6 immu-
noreactivity 96 h after transfection (Fig. 3, A and B). Mig6
siRNA also suppressed HGF-stimulated induction of Mig6 (Fig.
3 C; compare 4-h time point in the presence and absence of mig6
siRNA). The reduction of protein levels was specific for mig6,
because endogenous 
 
 
 
-tubulin and Met levels were unaffected
(Fig. 3 C and not depicted). To investigate the role of Mig6 pro-
tein in cell migration, cells were transfected with mig6 siRNA
oligonucleotides, and subjected to the Boyden chamber assay
with different concentrations of HGF (Fig. 3). Representative
images of Hoechst dye–labeled cells that migrated into the lower
compartment are shown in Fig. 3 (D–G). The induction of cell
migration by HGF under these conditions was less strong, yet
was still dose dependent (Fig. 3 H). Quantification of migrating
cells revealed that under conditions of optimal HGF concentra-
tions, knock down of Mig6 enhanced cell migration by approxi-
mately twofold (Fig. 3 H). Similar results were obtained with
a separate set of siRNA oligonucleotides (unpublished data).
These findings demonstrated that Mig6 is a physiologic inhibitor
of HGF/Met-mediated cell migration of MLP29 cells.
Knock-down of Mig6 also enhanced MLP29 cell prolif-
eration (unpublished data), as previously shown in EGF-stimu-
lated fibroblasts (Xu et al., 2005). To separate Mig6’s effects
on cell proliferation from cell migration, we assayed cell mi-
gration in the presence of the cell cycle inhibitor, aphidicolin.
In the presence of DMSO-containing control media, knock-
down of Mig6 protein levels led to a significant increase in
HGF-induced cell migration (Fig. 4, A, B, and E). This effect
was not diminished by the presence of aphidicolin, if anything,
it was enhanced slightly (Fig. 4, C–E). These data indicate that
endogenous Mig6 blocks cell migration independently of its
antiproliferative effects.
 
Cortical neuron migration induced by HGF 
is sensitive to overexpression of Mig6
 
We next asked whether the functions of Mig6 were specific to
cells of hepatic origin, or whether Mig6 had a more general
role in controlling cell migration across different cell lineages,
including neurons from the neocortex (Powell et al., 2001). To
test the consequences of Mig6 overexpression, embryonic cor-
tical neurons were transfected with a Mig6
 
FL-V5
 
 construct, and
Mig6 expression was monitored by immunofluorescence mi-
croscopy (Fig. 5, D–G). Our modified electroporation protocol
(see Materials and methods) led to transfection efficiencies of
40–70%, as judged by GFP fluorescence (Fig. 5 A). Mig6 over-
expression did not affect survival (unpublished data) or dif-
ferentiation of cortical neurons as judged by the expression of
microtubule-associate protein 2 (Fig. 5 B,C). HGF-induced cell
migration was assayed 36 h after transfection of expression
plasmids that encoded GFP or Mig6
 
FL-HIS
 
. Quantification of all
(transfected and untransfected) cells on the lower face of the
porous membrane revealed a three- to fourfold increase of mi-
grated cells in the presence of HGF, and a seven- to eightfold
stimulation among the GFP transfectants (Fig. 5 H). In con-
trast, overexpression of Mig6 completely prevented HGF from
inducing cell migration (Fig. 5 H). In a separate set of experi-
ments, we compared cells that were transfected with plasmids
that encoded Mig6
 
FL-V5
 
 or LacZ
 
V5
 
 in the absence or presence of
HGF. 24 h after transfection, LacZ
 
V5
 
 control cells responded to
HGF with a six- to sevenfold higher migration rate (Fig. 5 I). In
contrast, Mig6
 
FL-V5
 
-expressing cells failed to migrate (Fig. 5 I;
P 
 
 
 
 0.0001, 
 
t
 
 test). The effect of Mig6 on HGF-induced cell
migration was specific, because Mig6 was unable to block cell
migration in response to the chemokine stromal cell–derived
factor-1 (SDF-1) (Fig. 5 I; P 
 
 
 
 0.28, 
 
t
 
 test).
 
Mig6 suppresses HGF/Met-mediated 
neurite growth
 
Besides regulating cell migration, HGF is a chemoattractant
and neurite growth-promoting factor for subsets of neurons, in-
cluding sympathetic neurons (Maina and Klein, 1999; Thomp-
son et al., 2004). We next tested the effects of Mig6 on neurite
Figure 4. Physiologic inhibition of HGF-mediated cell migration by Mig6 is
independent of its effects on proliferation. Representative Hoechst dye–
labeled MLP29 cells that were transfected with GFP-specific siRNAs (A and
C) or Mig6-specific siRNAs (B and D) migrated onto the lower face of the Boy-
den chamber membrane upon stimulation with HGF. The cells were exposed
to media containing DMSO (A and B) or 1.6  g/ml aphidicolin solubilized
in DMSO (C and D). Bar, 100  m. (E) Quantification of cell migration ex-
pressed as fold of induction over unstimulated cells. Migration was enhanced
in cells transfected with Mig6 siRNAs (gray bars) compared with GFP si-
RNAs (black bars) in the absence or presence of aphidicolin (Aphid.) (P  
0.019 and P   0.0002, respectively, t test). *, P   0.05; **, P   0.01. 
JCB • VOLUME 171 • NUMBER 2 • 2005 342
 
growth of paravertebral sympathetic neurons. Most postnatal
day 40 sympathetic neurons of the superior cervical ganglion
survive in culture without addition of neurotrophic factors (un-
published data). Exogenous HGF induced Mig6 expression
(Fig. 6 A), and stimulated outgrowth and branching of neurites.
To quantify this effect, we transfected the cells with an expres-
sion plasmid that encoded YFP by way of gene gun, and used
Sholl analysis (see Materials and methods) to determine neurite
complexity. HGF (10 ng/ml) significantly increased neurite
complexity and branching as compared with nontreated control
cultures (Fig. 6, D and F). The effect was most pronounced
close to the soma, whereas there was no significant increase in
complexity in the longest neurites (Fig. 6 D). To investigate
neurite complexity, we compared the neurite arbors of cells
that were transfected with expression vectors encoding Mig6
plus YFP with cells expressing YFP alone (Fig. 6, B and C).
Overexpression of Mig6 greatly reduced neurite outgrowth and
branching of HGF-stimulated cells (Fig. 6 E). The effect was
most pronounced close to the cell soma, where HGF had its
strongest effects in comparison with control cDNAs, such as
YFP (Fig. 6 E). This effect was specific for HGF-treated neu-
rons, because in untreated neurons, expression of Mig6 did not
cause a reduction of branch points (Fig. 6 F). Exogenous Mig6
also did not affect survival of HGF-treated neurons, which sug-
gests that Mig6 specifically inhibited Met signaling toward
neurite growth (Fig. 6 G). We next performed Mig6 knock-
down experiments and found a modest increase in neurite
length in Mig6 siRNA-treated, as compared with GFP siRNA-
treated, cells. The increase in Mig6 knock-down cells was sig-
nificant in neurites that extended furthest from the soma. Be-
cause the induction of endogenous Mig6 protein is delayed (see
Fig. 6 A), the effect of knocking down mig6 mRNA may be
Figure 5. Mig6 overexpression in cortical neurons inhibits HGF-induced migration. Cortical neurons were dissected from E15.5 mouse embryos and
electroporated with expression plasmids encoding GFP (A) or Mig6
FL-V5. Electroporated cells were plated for 24 h (A, D–F) or 3 d (B and C) onto cover-
slips for immunocytochemical analysis. (A) GFP fluorescent cells (green) among untransfected Hoechst dye–labeled cells. (B and C) After transfection with
Mig6
FL-V5, cells were cultured for 3 d and immunostained with  -microtubule-associated protein 2 ( -MAP2) (B) or  -Mig6 ( -Mig) antibodies (C). Mig6 did
not affect neuronal differentiation. (D–G) Cells were fixed and doubly labeled using  -V5 (D) and  -Mig6 (E) antibodies. Nearly all V5-labeled cells also
express Mig6. Similar results were obtained with a HIS-epitope–tagged Mig6 expression plasmid (not depicted). (H) Quantification of Hoechst dye–labeled
cortical neurons that have migrated onto the lower face of the Boyden chamber membrane. Cells were left nonelectroporated ( ) or were electroporated
with expression plasmids encoding GFP or with Mig6
FL-HIS. Neurons were seeded onto the upper compartment of the Boyden chamber in the absence
(black bars) or presence (gray bars) of 50 ng/ml HGF. The cells were fixed and counted after 24 h. The expression of Mig6
FL-HIS completely prevented
HGF-mediated cell migration. (I) Quantification of migrating cortical neurons expressed as fold of induction over unstimulated cells. Cells were elec-
troporated with LacZ
V5 control or Mig6
FL-V5 expression plasmids in the presence of 50 ng/ml HGF or 100 ng/ml SDF-1. Mig6
FL-V5 inhibited HGF-induced
(P   0.0001, t test), but not SDF-1–induced, cell migration (P   0.28, t test). Bar, 50  m.MIG6-MEDIATED INHIBITION OF HGF/MET SIGNALING • PANTE ET AL. 343
visible only in the longest neurons that took the most time to
grow. These results suggest that Mig6 plays a role in suppress-
ing neurite complexity that is induced by HGF/Met signaling.
The CRIB domain of Mig6 is required for 
and sufficient to inhibit HGF-mediated 
cell migration
Mig6 was proposed to inhibit EGFR signaling by direct binding
to EGFR and ErbB2—by suppressing the EGFR kinase activ-
ity—and by a receptor distal mechanism (Anastasi et al., 2003).
To begin dissecting the mechanism of Mig6-mediated inhibition
of cell migration, we asked whether Mig6 would directly bind
Met in MLP29 cells that were stimulated with HGF. In pull-
down experiments that used bacterially expressed, GST-tagged,
purified, full-length Mig6, we were unable to demonstrate a di-
rect association between Mig6 and Met (unpublished data).
Moreover, the minimal region that was mapped in EGFR to be
essential for the binding of Mig6 is not found in the amino acid
sequence of mouse Met. However, pull-down experiments with
GST-tagged Mig6 confirmed the association with growth factor
receptor–bound protein 2 (Grb2) (Fig. 7 A), which had been ob-
served previously (Fiorentino et al., 2000). Control pull-downs
with the GST-tagged CRIB domain of P21-associated serine/
threonine kinase failed to pull down Grb2 (Fig. 7 A). This sug-
gested the possibility that Mig6 may bind Met indirectly by way
of Grb2, thereby inhibiting Met in a receptor-proximal fashion.
Figure 6. Mig6 inhibits HGF-induced neurite outgrowth and branching of sympathetic neurons. (A) Western blotting (W.B.) using an  -Mig6 antibody
showing the time course of endogenous Mig6 protein induction upon HGF stimulation in postnatal day 40 (P40) superior cervical ganglion (SCG) neurons
(top panel). The  -MAPK antibody was used as internal control. Representative P40 SCG neurons transfected with YFP (B) or with a mixture of YFP plus
Mig6
FL-V5 expression plasmids (C). Cells were grown in medium supplemented with 10 ng/ml HGF for 48 h. Note the significant reduction in neurite complex-
ity of the Mig6
FL-V5-expressing cell compared with YFP control. (D) Sholl analysis (see Materials and methods) of P40 SCG neurons transfected with YFP alone
and exposed for 48 h to control media (CON/YFP) or 10 ng/ml HGF (HGF/YFP). (E) Sholl analysis of P40 SCG neurons stimulated with 10 ng/ml HGF after
being transfected with YFP (black bars) or YFP plus Mig6
FL-V5 (gray bars). Mig6
FL-V5 expression was able to block HGF-induced neurite outgrowth completely
(compare panels D and E, gray bars). (F) Numbers of neurite branch points per neuron in different experimental conditions. P40 SCG neurons were treated
as described above, and the numbers of branch points per neuron were counted in the presence (HGF) or absence (CON) of 10 ng/ml HGF. (G) Percentage
of surviving P40 SCG neurons in different experimental conditions. After 48 h of HGF exposure, the neurons were transfected with the control LACZ
V5 or the
Mig6
FL-V5 expression plasmids. Upon stimulation with HGF, the expression of Mig6
FL-V5 did not affect P40 SCG neuron survival. (H) Sholl analysis of P40 SCG
neurons transfected with Mig6-specific or GFP-specific siRNA oligonucleotides together with an expression plasmid encoding YFP in the presence of
10 ng/ml HGF. Endogenous Mig6 knock-down by siRNA induced a modest increase in neurite branching. Distances in D, E, and H measured in  m.JCB • VOLUME 171 • NUMBER 2 • 2005 344
Figure 7. The CRIB domain of Mig6 is necessary and sufficient to inhibit HGF-induced cell migration. (A) Mig6 binds Grb2. GST-Mig6
FL and GST-
Mig6
 CRIB purified fusion proteins were used to pull down endogenous Grb2 from MLP29 total cell lysate. The fusion proteins were incubated for 1 h with
total (Tot.) cell lysate and pulled down using glutathione-sepharose beads. Pulled-down proteins were eluted from the beads and analyzed by SDS-PAGE.
Western blot (W.B.) analysis using an  -Grb2 antibody shows that Grb2 associates with Mig6, and that the association is independent of Mig6’s CRIB
domain. A GST-PAK
BD fusion protein was used as a negative control. (B) Mig6 reduces the levels of Cdc42-GTP. The GST-Ack-CRIB–purified fusion protein
was used to pull down (P.D.) the active form (GTP-bound) of transfected GFP-Cdc42 at different time points of HGF stimulation in the presence or the ab-
sence of Mig6 expression plasmid. MLP29 cells were transfected with GFP-Cdc42 plus GFP (left half) or GFP-Cdc42 plus Mig6
FL-V5 expression plasmids
(right half), starved for 48 h in 0.1% FBS, stimulated with 40 ng/ml of HGF for the indicated times, and lysed. The GST-Ack-CRIB protein was incubated
with the cell lysates, pulled down using glutathione-sepharose beads, eluted from the beads, and analyzed by SDS-PAGE. Western blot (W.B.) analysis us-
ing an anti-GFP–specific antibody showed that exogenous GFP-Cdc42 is activated upon 15 and 30 min ( ) of HGF stimulation. The expression of Mig6
significantly reduced exogenous GFP-Cdc42 activation upon HGF stimulation (compare 15- and 30-min time points, left and right part of the blot). Western
blot analysis on total cell lysates (TCL) using an anti-GFP–specific antibody was used to control that comparable amounts of total GFP-Cdc42 were used for
the pull down. (C) Schematic representation of the different GST-Mig6 deletion mutants. 14-3-3, 14-3-3 binding region; AH, Ack homology domain; PDZ,
PDZ target site; SH3BM, SH3 binding site. (D, left blot) GST-Mig6
FL, GST-Mig6
 CRIB, GST-Mig6
NT, and GST-Mig6
CRIB were transfected in MLP29 cells and
pulled down using glutathione-Sepharose beads (Glut.). The proteins were eluted from the beads and analyzed by SDS-PAGE. Western blot (W.B.) analy-
sis using an  -GST antibody shows that the Mig6 fusion proteins were expressed at similar levels. Transfection with YFP expression plasmid was used as a
negative control for the  -GST antibody. (D, right blot) GST-Mig6
FL plus GFP-Cdc42*, GFP-Cdc42*, or GST-Mig6
FL plus GFP expression plasmids were
transfected in MLP29 cells. The cells were lysed, and total cell lysates analyzed by SDS-PAGE. Western blot analysis using an anti-GST– (top panel) and
an anti-GFP (bottom panel) specific–antibody shows that the exogenous Mig6 and Cdc42* (arrowheads) are expressed at equal levels. Transfection of
GFP expression plasmid was used as a negative control for the anti-GST and anti-GFP antibodies. Asterisk in panel D denotes an unspecific cross-reactive
protein that is detected with anti-GST antibodies. Quantification of cell migration expressed as fold of induction over unstimulated cells in the presence of
10% FBS (E and G) or HGF (F and H). MLP29 cells were left untransfected or were transfected with the indicated GST-Mig6 expression plasmids (E and F)MIG6-MEDIATED INHIBITION OF HGF/MET SIGNALING • PANTE ET AL. 345
We next addressed the relevance of the Mig6 CRIB do-
main, which had been suggested to bind the Rho family GTPase,
Cdc42 (Makkinje et al., 2000). HGF activated Rho family GTP-
ases in epithelial cells concomitant with cell-spreading re-
sponses, which was inhibited by dominant negative Cdc42 or
Rac (Royal et al., 2000). Mig6 shares striking homology with the
noncatalytic region of the cytoplasmic tyrosine kinase, activated
Cdc42-associated tyrosine kinase (Ack), which interacts with
Cdc42 by way of its CRIB domain and inhibits Cdc42’s GTPase
activity (Mott et al., 1999). Using the yeast two-hybrid assay, we
first confirmed that full-length Mig6 bound Cdc42 with higher
affinity than Rac (Fig. S2). We then asked if Mig6 would prevent
the activation of Cdc42 in MLP29 cells. HGF stimulation of
MLP29 led to an increase in the levels of GTP-bound Cdc42, as
shown by pull-down experiments of transfected Cdc42 using the
Ack-CRIB domain (Fig. 7 B). Cotransfection of Cdc42 with
Mig6 essentially eliminated this effect (Fig. 7 B). We next inves-
tigated if the CRIB domain of Mig6 was essential for Mig6’s in-
hibition of HGF-induced cell migration. We generated GST-
tagged versions of Mig6 lacking the CRIB domain; a truncated
NH2-terminal fragment of Mig6 including the CRIB domain, but
lacking the Ack homology domain; and the isolated CRIB do-
main only, and expressed them in MLP29 cells (Fig. 7 C). The
mutant proteins were expressed at similar levels (Fig. 7 D) and in
similar subcellular compartments (Fig. S2).
Next, we analyzed HGF-induced cell migration. Mig6
FL
inhibited cell migration twofold (Fig. 7 F). In contrast, Mig6
lacking the CRIB domain had no effect on HGF-induced cell
migration (Fig. 7 F). The NH2-terminal fragment of Mig6 in-
cluding the CRIB domain and, more importantly, the isolated
CRIB domain inhibited HGF-induced cell migration to the
same extent as did Mig6
FL (Fig. 7 F). The effects were specific
for HGF-stimulated cells, because cell migration that was in-
duced by FBS was not affected by ectopic expression of Mig6
including the CRIB domain, but lacking the Ack homology do-
main, or CRIB (Fig. 7 E). If the mechanism of Mig6 action in-
volved the binding and inhibition of Cdc42, the coexpression
of dominant-active Cdc42 (Cdc42*) may rescue the antimigra-
tory effect of Mig6. To test this, we cotransfected MLP29 cells
with Mig6
FL and GFP or with the same amounts of Mig6
FL and
Cdc42* expression plasmids, and performed cell migration as-
says. The combination of Mig6
FL and GFP led to an efficient
block of migration, whereas the coexpression of Mig6
FL and
Cdc42* completely rescued cell migration. Expression of
Cdc42* alone had no significant effect in this assay (Fig. 7 H).
These results suggest that the CRIB domain of Mig6 is neces-
sary and sufficient for inhibition of HGF-induced cell migra-
tion. They further suggest that part of Mig6’s mechanism of ac-
tion involves the regulation of Rho GTPases, such as Cdc42.
Discussion
The complex chain of events that attenuates signal transduction
of receptor tyrosine kinases remains poorly understood. Recent
studies revealed that negative receptor signaling involves intri-
cate interactions between ubiquitin ligases, adaptor proteins,
inhibitory proteins, cytoplasmic kinases, and phosphatases
(Dikic and Giordano, 2003). Although some of these negative
regulators can act on rather specific targets (protein tyrosine
phosphatase inhibits insulin and insulin-like growth factor–1–
stimulated signaling), others seem to inhibit multiple receptor
tyrosine kinases (e.g., c-Cbl ubiquitin ligase) and generic sig-
naling pathways. In this report, we show that Mig6 is induced
by HGF in different cell lineages. Mig6 negatively regulates
HGF/Met-mediated cellular responses, including cell migration
and neurite growth. This suggests that Mig6 is part of a physio-
logic mechanism that negatively controls the strength and dura-
tion of Met signaling, thereby fine tuning signal transduction.
Although further experiments are needed to clarify the exact
mechanism of Mig6 action, our data suggest an important role
for Mig6 interaction with Rho family GTPases.
Mig6 induction by external signals
We identified Mig6 in MLP29 cells as an RNA transcript that
was induced highly by HGF and EGF and rather weakly by
FGF2 and PDGF. Other investigators found that Mig6 was in-
duced by serum, EGF and related ligands, and cellular stress
factors (Wick et al., 1995; Makkinje et al., 2000; and refer-
ences within). We have provided evidence that Met signaling
is a major pathway for Mig6 expression in vivo by showing a
reduction of mig6 transcript levels in embryonic liver and
lung of mouse mutants expressing a severe signaling hypo-
morph of Met (Fig. 1). We conclude that in many circum-
stances, Mig6 is expressed at low levels, and its expression is
induced by HGF/Met signaling to activate feedback inhibition
with some delay after the initiation of Met signaling. Conse-
quently, the cell responds robustly to Met signaling, until
Mig6 levels are high enough to attenuate the Met response.
Alternatively, other external signals may have induced the ex-
pression of Mig6 before the cells were exposed to HGF,
thereby reducing the cell’s ability to respond to Met signaling.
Loss of the ability to induce the expression of Mig6 may be
part of the multiple step process toward malignancy. Consis-
tent with this model, a recent large-scale expression profiling
study noted that Mig6 expression was down-regulated in pa-
tients who had breast cancer with short survival time (Am-
atschek et al., 2004). It seems as if loss of Mig6 provides a
growth advantage and perhaps metastatic potential for breast
cancer cells.
or cotransfected with a combination of GFP-Cdc42* and GST-Mig6
FL expression plasmids as indicated (G and H) and seeded onto the upper compartment
of the Boyden chamber. The NH2-terminal half of Mig6 (Mig6
NT) and its CRIB domain (Mig6
CRIB) were able to inhibit HGF-mediated migration significantly
compared with control cells (for both P   0.001, t test) (panel F). **, P   0.01. In contrast, Mig6
 CRIB was not able to reduce HGF-mediated migration
significantly compared with untransfected control (P   0.88, t test). The inhibition of HGF-mediated migration due to GST-Mig6
FL expression was rescued
significantly by the coexpression of GFP-Cdc42* (P   0.76), but not of GFP expression plasmids (average of three separate experiments; P   0.0001).
10% FBS-induced cell migration was not affected by any of the Mig6-expressing constructs (E and G).JCB • VOLUME 171 • NUMBER 2 • 2005 346
Mig6 modulates a variety of cellular 
responses
Previous work showed that Mig6 inhibits cell proliferation
downstream of ErbB family receptors (Fiorentino et al., 2000;
Hackel et al., 2001; Anastasi et al., 2003). This includes studies
in which Mig6 was silenced by RNA interference, and provided
first evidence for its role as an endogenous inhibitor of EGFR-
mediated proliferation (Anastasi et al., 2005; Xu et al., 2005).
Until now, the role of Mig6 in ErbB-mediated cell migration had
not been addressed. However, this is an important question; nu-
merous studies demonstrated that EGF and related ligands for
EGFR/ErbB receptors stimulate chemotactic migration in verte-
brate and invertebrate systems (Wells and Lillien, 2004). Our
study has concentrated on the role of Mig6 in Met-mediated cell
migration, a process that is implicated in several physiologic
contexts, including myoblast migration during development,
scattering and branching morphogenesis of epithelial cells, and
neuronal migration in the developing forebrain (Powell et al.,
2001; Birchmeier et al., 2003; Rosario and Birchmeier, 2003).
Met signaling also is critical for neurite extension and branching
of different neuronal subpopulations (Maina and Klein, 1999;
Thompson et al., 2004), a process that has similarities with inva-
sive growth of malignant cells (Trusolino and Comoglio, 2002).
We found that Mig6 overexpression effectively and specifically
reduced HGF-induced migration of a cell line of hepatic origin
and of primary cortical neurons. Mig6 also effectively blocked
HGF-induced neurite growth of primary sympathetic neurons. In
converse experiments, mig6 knock-down effectively enhanced
cell migration of hepatic progenitor cells and mildly, yet signifi-
cantly, enhanced neurite growth of sympathetic neurons.
Mig6 acts distally from Met by way of 
interaction with Rho family GTPases
Mig6 is a multiadaptor molecule whose amino-terminal 38
amino acid residues show homologies with the conserved
CRIB domain that is present in a variety of intracellular signal-
ing molecules (Pirone et al., 2001). Mig6 contains putative
binding sites for SH3-containing molecules such as Grb2,
PI3K, and PLC  (Fiorentino et al., 2000), and for 14–3-3 and
PDZ-domain containing proteins. Notably, Mig6 includes a
COOH-terminal region that is highly homologous to the non-
catalytic portion of Ack1. A region within this Ack1 homology
domain was identified as an EGFR-binding motif (Fiorentino
et al., 2000; Anastasi et al., 2003) that was necessary and suffi-
cient for the inhibition of EGFR signaling (Xu et al., 2005). Ex-
pression of Mig6/receptor-associated late transducer in tumor
cells modestly reduced the levels of ErbB-mediated phospho-
MAPK and phospho-Akt expression, which suggested some in-
terference with mitogenic signaling pathways (Anastasi et al.,
2005). Conversely, loss of Mig6 led to sustained MAPK phos-
phorylation in EGF-stimulated keratinocytes (Ballaro et al.,
2005 and unpublished data). The association between Mig6
and Met by way of Grb2 interaction (Fig. 7) suggests the possi-
bility that Mig6 inhibits Met signaling in a receptor-proximal
fashion. However, we have been unable to detect changes in
the levels of Met-mediated phospho-MAPK and phospho-Akt
expression in cells that transiently overexpress Mig6 (Fig. S2).
Therefore, we favor the view that the antimigratory effect of
Mig6 in MLP29 cells involves other pathways.
Because the CRIB domain of Mig6 binds Cdc42 in a
GTP-dependent manner (Makkinje et al., 2000 and this report),
HGF stimulation activates Cdc42, and activated Cdc42 is
required for HGF-induced lamellipodia formation and cell
movement (Royal et al., 2000), we favor the possibility that
Mig6 inhibits Cdc42-mediated cell movement by way of its
CRIB domain. In support of this hypothesis, we show that (i)
overexpression of a Mig6 construct lacking the CRIB domain,
but retaining Grb2-binding capabilities, is unable to suppress
HGF-induced migration; (ii) overexpression of the Mig6 CRIB
domain alone is sufficient to inhibit HGF-induced migration;
and (iii) coexpression of Mig6 with a dominant-active form of
Cdc42 rescues the antimigratory effects of Mig6. Therefore,
the mechanism of Mig6 inhibition of Met resembles the mech-
anism of Ack1 inhibition of EGFR. The Caenorhabditis elegans
orthologue of Ack1, Ark, associates with EGFR by way of
binding to Sem5, the C. elegans orthologue of Grb2 (for review
see Worby and Margolis, 2000). Similar to Mig6, overexpres-
sion of the CRIB domain of Ack1 is sufficient to inhibit growth
factor–induced activation of Cdc42 (Nur-E-Kamal et al., 1999).
Furthermore, overexpression of the CRIB domain of another
small GTPase-binding protein, PAK (an effector of Rac1), by
way of its interaction with Rac1, inhibits Semaphorin 3A-induced
growth cone collapse (Vastrik et al., 1999). Together, these
results indicate that CRIB domains are sufficient to inhibit the
biologic effects of specific GTPases.
We propose that Mig6 is part of a network of negative sig-
naling molecules that fine tune and attenuate Met and ErbB signal-
ing in development and disease. The analysis of mig6 mutant mice
provided genetic evidence for a role of Mig6 in the maintenance of
joints and cartilage (Zhang et al., 2005) and in skin morphogenesis
and cancer (unpublished data). They will be an invaluable tool in
our efforts to elucidate the inhibitory functions and molecular in-
teractions of Mig6 in the context of an intact tissue.
Materials and methods
Mouse 15,000 cDNA microarray production and data analysis
The “NIA mouse 15k cDNA microarray” chip production, isolation of RNA,
labeling of cDNA probes, and hybridization to the cDNA array was per-
formed as described (Cortes-Canteli et al., 2004). In brief, the hybridization
was performed in duplicate using total RNA samples that were extracted
from two independent batches of cultured cells. Stimulated and mock-treated
samples were labeled by Cy-5 and Cy-3-dUTP, respectively. Data acquisi-
tion and initial data analysis were performed with GenePix Pro 3.0, and
data tables were analyzed further in Microsoft Excel to obtain the gene list.
Quality control was performed by eye to confirm scanner alignment and ab-
sence of significant bubbles and scratches. Scatter plots were used further to
eliminate the unacceptable hybridization data. GenePix Pro program calcu-
lates the normalization factor of each hybridization, based on the premise
that the arithmetic mean of the ratios from every feature on the given array
should be equal to 1. Therefore, normalization was performed by multiply-
ing the factor to ratio of medians (ROM) in each gene. The genes that
passed all of these criteria were sorted first by sum of median (SOM), which
indicates the intensity of hybridization. To obtain the list of genes that are
relatively abundant, the genes that showed more than 5,000 of SOM were
selected. Finally, the genes were sorted by ROM. The genes that showed
more than   1.8-fold changes were selected in the data table from each hy-
bridization. Finally, the data were compared between the two hybridiza-
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based on the information given in the NIA mouse 15k cDNA clone gene ID
list at the first instance and modified when necessary.
Northern blots
Total RNA was extracted from different cell lines in various experimental
conditions using the RNAClean Solution (Hybaid). 20  g total RNA was
electroporated and blotted onto Genescreen nylon membrane (NEN Life
Science Products). Labeled probes were generated using random primers
and hybridized (6  SSC, 5  Denhardt solution, and 100  g salmon
sperm DNA) with the membrane for 18 h at 65 C. cDNA inserts used as
probes were obtained by NotI/SalI double restriction digestion of the NIA
mouse 15k cDNA clones.
RNA interference
siRNA oligonucleotides (first set [AAGGUCAAGCUUGCCCCCUC-dTdT]
and second set [GAGGAUCAAGUUAUGUGUGG-dTdT]) were designed
and used for cell transfections as described (Elbashir et al., 2001). Sense and
anti-sense siRNA oligonucleotides (DARMAKOM) were diluted in anneal-
ing buffer (100 mM K-Acetate, 30 mM Hepes-KOH, 2 mM Mg-Acetate) to
the final concentration of 20  M, denatured for 1 min at 90 C, and an-
nealed by incubation for 1 h at 37 C. 6  l siRNA duplex was transfected
into 4   10
4 cells using oligofectamine (Invitrogen), according to the man-
ufacturer’s instructions. After transfection, cells were left in Dulbecco’s min-
imum essential medium (DMEM) plus 0.1% FBS for 72 h and transfected a
second time with the same siRNA duplex. The aphidicolin treatment was
performed as described above. 24 h after the second transfection, cells
were harvested and plated on the upper face of the Boyden chamber as
described above.
Plasmids and expression vectors
Primer sequences are available upon request. The V5 COOH-terminal,
GST NH2-terminal, and His COOH-terminal tagged Mig6 full-length and
mutant proteins were generated using the Gateway Cloning technology
according to the manufacturer’s instructions (Invitrogen). In brief, Mig6
full-length and deletion mutants were amplified by PCR from the IRAK
clone IRAKp961F0910 using oligonucleotides that contained the minimal
recombination sequences (5 -ATTB1 and 3 -ATTB2). PCR amplified prod-
ucts were recombined into pDONOR201 vector by the use of a mixture
of recombination proteins that was provided by the manufacturer. The
pDONOR201 vectors containing Mig6 full-length or deletion mutants
were shuttled into pCDNA 6.2 COOH-terminal-V5, pDEST 27 NH2-termi-
nal-GST, and pDEST26 NH2-terminal-His plasmids (all Invitrogen) for mam-
malian expression or into pDest15 N-term-GST for bacterial expression.
The LacZ-V5 expression plasmid was purchased (Invitrogen). GFP-
Cdc42
WT and dominant active expression plasmids were provided by M.
Way. The CRIB domain of Ack was amplified by PCR from the I.M.A.G.E.
Consortium cDNA Clones (Clone ID IMAGp998I1013902Q3) (Lennon et
al., 1996) and was subcloned into pCRII-TOPO cloning vector (Invitrogen)
following the manufacturer’s instructions. The fragment was inserted into
the pFAT2 vector for bacterial expression. The pGEX-NH2-terminal-GST-
Mig6, containing the Mig6 COOH-terminal half (from aa 273 to 459),
was provided by A. Ullrich and was used to produce the Mig6 antigen.
Primary cortical neuron culture, cell migration assays, and growth factors
MLP29 cells were cultured and transiently transfected as described (Muller
et al., 2002). C2C12 were grown as described (Yaffe and Saxel, 1977).
Primary hepatocytes were cultured as described (Maina et al., 2001). The
transwell assay was performed as described previously (de Luca et al.,
1999). In brief, 10
5 MLP29 cells were seeded on the upper face of the
Boyden chamber membrane (8  m pore; Costar), which was coated pre-
viously with 0.15  g/cm
2 of fibronectin (Sigma-Aldrich). The cells were
stimulated with 40 ng/ml of hepatocyte growth factor (HGF) (R&D Sys-
tems), 10 ng/ml EGF, 30 ng/ml PDGF (Sigma-Aldrich), 25 ng/ml fibro-
blast growth factor 2 (FGF2; Sigma-Aldrich), and 100 ng/ml SDF-1 (Cal-
biochem). To assay cell migration in the absence of cell proliferation, cells
were treated for 24 h before and during the migration assay with DMSO-
(Fluka) or 1.6  g/ml aphidicolin-containing media (Sigma-Aldrich).
Cortical neurons were obtained by digestion of E15.5 mouse telen-
cephalon for 15 min at 37 C with trypsin-EDTA (GIBCO BRL). The neurons
were washed twice with DMEM-F12 supplemented with 10% horse serum
(GIBCO BRL), washed once in neurobasal medium containing B27 supple-
ment (NB/B27, 50:1, GIBCO BRL) and were dissociated with a fire-pol-
ished glass Pasteur pipette. Cortical neurons were dissected and elec-
troporated by mixing 6   10
5 cells with 24  g expression plasmid,
transferred into an electroporation cuvette (MBP Molecular Bioproducts),
and electroporated (five pulses at 270 V of 3 msec separated by 1-s inter-
val) using the Electrosquare porator (ECM830, BTX). The cells were incu-
bated for 10 min at 4 C. 10
5 cells were seeded on the upper side of the
Boyden chamber (5- m pore, Costar), which was coated previously with
poly-D-ornithin (Sigma-Aldrich). 3 h later, the appropriate growth factors
were added to the lower compartment for 18 h. The cells were fixed with
4% PFA (Merck) for 30 min at room temperature and incubated for 10
min at 4 C. Boyden chamber filters were mounted onto glass coverslips in
the presence of vectashield/DAPI (Vector Laboratories). The cells were
analyzed directly under a Zeiss Axiophot fluorescent microscope.
In situ hybridization and biochemistry
In situ hybridizations and preparations of probes were performed as de-
scribed (Helmbacher et al., 2003). Mig6 sense and anti-sense probes
were obtained by NotI and SalI restriction digests of the NIA clone
h3011f08. The met in situ probe was described previously (Helmbacher
et al., 2003). Immunoblotting and immunocytochemistry were performed
as described (Maina et al., 2001). Recombinant GST-Mig6 fusion pro-
teins were purified according to standard procedures. MLP29 cell lysates
were incubated for 1 h at 4 C with recombinant proteins that were immo-
bilized on glutathione-sepharose. The glutathione-sepharose beads were
washed several times in cell lysis buffer, eluted with sample buffer, and
analyzed by immunoblotting.
Antibodies
The rabbit anti-Mig6 antibody was generated as described previously
(Hackel et al., 2001). The anti-phospho-MAPK, anti-MAPK, and anti-phos-
pho-Akt (New England Biolabs, Inc.) antibodies were used as described
previously (Maina et al., 2001). Antibody dilutions: monoclonal anti-tubu-
lin (Sigma-Aldrich) 1:2,000 for Western blot (WB) analysis; monoclonal
anti-V5 (Invitrogen) 1:1,000 and 1:250 for WB and immunocytochemical
(IC) analysis, respectively; rabbit polyclonal anti-Met (BIOMOL Research
Laboratories) and anti-GST (Santa Cruz Biotechnology, Inc.) 1:500 for
WB analysis; anti–microtubule-associated protein 2 (Sigma-Aldrich)
1:10,000 for IC analysis; monoclonal anti-Grb2 (Transduction Labs)
1:1,000 for WB analysis; donkey polyclonal anti–mouse Alexa488 (Mo-
lecular Probes) and anti–rabbit CY3 (Jackson ImmunoResearch Laborato-
ries) 1:200 for IC analysis; and polyclonal goat anti–mouse and anti–rab-
bit HRP-conjugated (GE Healthcare) 1:2,000 for WB analysis.
Imaging
All cell images were obtained with an Axioplan-2 imaging fluorescent mi-
croscope (Carl Zeiss MicroImaging, Inc.) equipped with a RT Slider 2.3.1
digital color camera (Diagnostic Instruments). A 40  objective was used,
except for the in situ hybridization images that were taken with a 20 
lens (Carl Zeiss MicroImaging, Inc.).
Yeast two-hybrid system
The NH2-terminal half of Mig6 and the CRIB domain of PAK and Ack were
inserted by way of BamHI/XhoI into the yeast two-hybrid prey vector
pAct2. Cdc42
WT and Rac
WT were inserted by way of BamHI/SalI into the
pGBT9 bait vector. These plasmids were transformed in the indicated
combination into the reporter strain PJ69-4A according to the CLON-
TECH Laboratories yeast protocol handbook. The double transformants
were selected by plating onto synthetic media lacking leucine and tryp-
tophane with 2% glucose as the carbon source (Leu /Trp ). Double
transformants were restreaked onto Leu /Trp  or synthetic media lacking
leucine, tryptophan, histidine, and adenine (quadruple drop out).
Recombinant protein purification and Cdc42 activation assay
Recombinant GST fusion proteins were purified according to standard
procedures. MLP29 cell lysates were incubated for 1 h at 4 C with recom-
binant proteins immobilized on glutathione-sepharose. The glutathione-
sepharose beads were washed several times in cell lysis buffer, eluted
with sample buffer, and analyzed by immunoblotting. For the Cdc42 acti-
vation assay, MLP29 cells in various experimental conditions were lysed
(50 mM Tris-Cl pH 7.4, 5 mM MgCl2, 200 mM NaCl, 1 mM sodium
orthovanadate, 1% NP-40, 10% glycerol, and a mixture of protease in-
hibitors EDTA-free), and the lysates were incubated with the recombinant
GST-Ack-CRIB protein bound to glutathione-sepharose beads for 1.5 h at
4 C. The proteins were eluted from the beads, and analyzed by SDS-
PAGE and immunoblotting.
Paravertebral sympathetic neuron cultures
Superior cervical ganglia were dissected from postnatal day 40 (P40)
CD1 mice. Neuron cultures were set up as described (Thompson et al.,
2004). HGF stimulation and quantification of neuronal survival was doneJCB • VOLUME 171 • NUMBER 2 • 2005 348
as described (Thompson et al., 2004). Sholl analysis was performed as
described previously (Sholl, 1953). For protein extraction, primary cul-
tures of dissociated P40 superior cervical ganglion neurons were grown
for 3–6 h in culture before being stimulated for different times with HGF.
Cells were harvested and homogenized as described above.
Online supplemental material
Fig. S1 shows Northern blot analysis of selected genes from the gene list.
Fig. S2 shows the effects of Mig6 on canonical Met signaling, yeast two-
hybrid interactions between Mig6 and Cdc42/Rac, and immunohis-
tochemical analysis of overexpressed and endogenous Mig6. Table S1
and Table S2 list the genes that are regulated by HGF in MLP29 cells.
Online supplemental material available at http://www.jcb.org/cgi/content/
full/jcb.200502013/DC1.
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